The science behind our approach
Two formulation technologies developed by Lavi MD sit behind the preparations on our price list: one for how nasal sprays are delivered, one for how peptide formulations are kept stable. Here is what each is, and what it is not.
Filtraphorix™
Nasal delivery for peptide formulations
The nasal spray base used in our nasal formulations, developed to support absorption across the nasal lining.
CryoBuffer™
Cold-prepared stabilisation for peptide formulations
A cold preparation and buffering process intended to keep peptide formulations stable in liquid form.
Read this first
What a formulation technology can and cannot tell you
- These are manufacturing and delivery processes. They describe how a preparation is made and taken, not whether a compound works.
- Compounded medications are not FDA-approved. Neither technology changes that.
- Lavi MD states that its claims about both technologies have not been evaluated by the FDA, and cites no clinical data for either.
- Where a figure is described by the source as projected rather than measured, we say so on the page.